bonyf NV

Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives

bonyf NV: bonyf’s 2023 financial statements made available

Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream

2024 Sales Forecast: Unprecedented Growth on the Horizon

bonyf exhibits at PLMA Amsterdam on 28-29 May 2024

bonyf Advances to Phase 2 in Development of Alginate-Organic Denture Fixative Cream

bonyf NV: bonyf’s 2022 financial statements made available

bonyf NV: Delay in release of financial statements 2022

bonyf NV: Trading Suspension

bonyf NV: 25% increase in turnover in H1 2022

bonyf NV: ANNUAL RESULTS 2021

bonyf NV: bonyf accelerates its export dynamics signing two new commercial contracts in Southeast Asia

bonyf NV: bonyf appoints Ben Mettepenningen as International Business Manager

bonyf NV: BLEEDING WHILE BRUSHING TEETH IS A SIGN OF GUM DISEASE, A CONDITION LINKED TO THE DEVELOPMENT OF ALZHEIMER’S DISEASE

Are vaseline-based denture creams a cause for health concern? bonyf offers an alternative solution to this latest controversy

bonyf NV: TO MARK WORLD ORAL HEALTH DAY, BONYF IS RAISING AWARENESS OF THE IMPORTANCE OF TEETH AND GUM HEALTH WITH ITS INNOVATIVE TECHNOLOGY

bonyf NV: BONYF, THE EXPERTS IN NEXT GENERATION ORAL AND DENTAL CARE GOES PUBLIC TODAY

bonyf NV: BONYF ANNOUNCES LISTING ON PARIS EURONEXT